Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Eksp Klin Farmakol ; 69(3): 58-62, 2006.
Artigo em Russo | MEDLINE | ID: mdl-16878503

RESUMO

In experimental and clinical investigations, assessment was made of mutagenous, antimutagenous, pro- and antiradical activity of some neurotropic preparations--cerebrolysin, encephabol (pyritinol), nootropil (piracetam), actovegin and cavinton (vinpocetine). In chemical, fermentative and cellular model systems, cerebrolysin inhibited generation of superoxide anion-radical, nitrogen monoxide and final products of degradation of fatty acids. Other preparations showed both anti- and prooxidant effect. The most pronounced anticlastogenic activity during expriments on C. capillaries had a cerebrolysin. Encephabol had the most prooxidant effect and low anticlastogenic activity. The ability of such preparations as ceredrolysin and encephabol to decrease erythrocyte high level with micronuclei in peripheric blood of patients with infantile cerebral palsy (spastic diplegia) was clinically investigated. The modifying effect of preparations was not univalent: it was cerebrolysin that decreased intensivity of aneu- and clastogenesis in patients in a greater degree than encephabol. A protective effect of these preparations was pronounced on the 10th day in group of the boys, and on the 20th day in the group of the girls.


Assuntos
Antioxidantes/administração & dosagem , Paralisia Cerebral/tratamento farmacológico , Crepis/fisiologia , Fármacos Neuroprotetores/administração & dosagem , Antioxidantes/farmacologia , Paralisia Cerebral/metabolismo , Criança , Pré-Escolar , Crepis/citologia , Ácidos Graxos/metabolismo , Feminino , Humanos , Masculino , Fármacos Neuroprotetores/farmacologia , Óxido Nítrico/metabolismo , Oxirredução/efeitos dos fármacos , Superóxidos/metabolismo , Fatores de Tempo
2.
Bull Exp Biol Med ; 132(1): 666-9, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11687849

RESUMO

Purine receptor agonists adenosine, cyclohexyladenosine, phenylisopropyladenosine, dimethylaminopurine riboside, ATP, and ADP reduced the level of chromosome aberrations and the number of micronuclei induced by ethylmethane sulfonate and cyclophosphamide in plants (Crepis capillaris) and mice. Possible mechanisms of the protective effect of these ligands are discussed.


Assuntos
Aberrações Cromossômicas , Crepis/genética , Mutagênese , Mutagênicos/farmacologia , Agonistas Purinérgicos , Animais , Células da Medula Óssea/efeitos dos fármacos , Células da Medula Óssea/fisiologia , Crepis/efeitos dos fármacos , Ciclofosfamida/farmacologia , Eritrócitos/efeitos dos fármacos , Eritrócitos/metabolismo , Metanossulfonato de Etila/farmacologia , Humanos , Ligantes , Masculino , Camundongos , Micronúcleos com Defeito Cromossômico , Testes para Micronúcleos , Testes de Mutagenicidade , Receptores Purinérgicos/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA